VF
APRE icon

Virtu Financial’s Aprea Therapeutics APRE Stock Holding History

Virtu Financial’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-983
Closed -$15K – 1699
2022
Q2 		$15K Buy
983
+291
+42% +$6.71K ﹤0.01% 1374
2022
Q1 		$26K Sell
692
-1,406
-67% -$57.6K ﹤0.01% 1259
2021
Q4 		$120K Buy
+2,098
New +$185K 0.01% 1053
2021
Q3 		– Sell
-2,057
Closed -$201K – 1470
2021
Q2 		$201K Buy
2,057
+1,533
+293% +$142K 0.02% 991
2021
Q1 		$53K Sell
524
-677
-56% -$79K ﹤0.01% 1422
2020
Q4 		$118K Buy
+1,201
New +$571K 0.01% 1015

Other funds holding APRE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's APRE Position: Q3 2022 in Review

Virtu Financial sold out of Aprea Therapeutics (APRE) in Q3 2022, closing a stake of 983 shares — an estimated $15K sold.

Virtu Financial first reported a position in APRE in Q4 2020 and held it in 6 quarters. The position peaked at $201K in Q2 2021. 26 funds tracked by Wall St. Rank hold APRE as of Q3 2022.

  • Virtu Financial reported no remaining Aprea Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 983 Aprea Therapeutics shares in Q3 2022, an estimated $15K.
  • Virtu Financial first reported a position in Aprea Therapeutics in Q4 2020 and held it in 6 quarters.
  • Virtu Financial's Aprea Therapeutics position peaked at $201K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.